
Albemarle Corporation – NYSE:ALB
Albemarle stock price today
Albemarle stock price monthly change
Albemarle stock price quarterly change
Albemarle stock price yearly change
Albemarle key metrics
Market Cap | 10.48B |
Enterprise value | 12.28B |
P/E | -5.54 |
EV/Sales | 1.88 |
EV/EBITDA | -6.04 |
Price/Sales | 1.59 |
Price/Book | 1.01 |
PEG ratio | -0.05 |
EPS | 2.88 |
Revenue | 8.39B |
EBITDA | -501.91M |
Income | 337.34M |
Revenue Q/Q | -47.26% |
Revenue Y/Y | -4.27% |
Profit margin | -28.8% |
Oper. margin | -35.96% |
Gross margin | -11.83% |
EBIT margin | -35.96% |
EBITDA margin | -5.98% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeAlbemarle stock price history
Albemarle stock forecast
Albemarle financial statements
$118.86
Potential upside: 47.64%
Analysts Price target
Financials & Ratios estimates
Jun 2023 | 2.37B | 650.04M | 27.43% |
---|---|---|---|
Sep 2023 | 2.31B | 302.53M | 13.09% |
Dec 2023 | 2.35B | -617.68M | -26.22% |
Mar 2024 | 1.36B | 2.44M | 0.18% |
Paying a dividend while loss making.
Payout ratio | -14.36% |
---|
2019 | 1.97% |
---|---|
2020 | 1.03% |
2021 | 0.66% |
2022 | 0.73% |
2023 | 1.1% |
Jun 2023 | 19109668000 | 9.02B | 47.21% |
---|---|---|---|
Sep 2023 | 18883354000 | 8.72B | 46.18% |
Dec 2023 | 18270652000 | 8.60B | 47.1% |
Mar 2024 | 19032333000 | 7.23B | 38% |
Jun 2023 | 73.70M | -513.69M | 245.88M |
---|---|---|---|
Sep 2023 | 628.85M | -662.92M | 99.69M |
Dec 2023 | -98.21M | -1.06B | 397.00M |
Mar 2024 | 97.95M | -494.50M | 1.55B |
Albemarle alternative data
Sep 2023 | 7,400 |
---|---|
Oct 2023 | 7,400 |
Nov 2023 | 7,400 |
Dec 2023 | 7,400 |
Jan 2024 | 7,400 |
Feb 2024 | 7,400 |
Mar 2024 | 9,000 |
Apr 2024 | 9,000 |
May 2024 | 9,000 |
Jun 2024 | 9,000 |
Jul 2024 | 9,000 |
Albemarle other data
Period | Buy | Sel |
---|---|---|
May 2024 | 0 | 2318 |
Nov 2024 | 0 | 1060 |
Dec 2024 | 0 | 2525 |
Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
---|---|---|---|---|---|---|---|
Sale | MASTERS J KENT director, officer: Chairman & CEO | Common Stock | 2,525 | $101.12 | $255,328 | ||
Sale | JOHNSON NETHA N. officer: Chief Op.. | Common Stock | 1,060 | $106.04 | $112,402 | ||
Sale | JOHNSON NETHA N. officer: Chief Op.. | Common Stock | 1,060 | $106.04 | $112,402 | ||
Option | SHEOREY NEAL RAVI officer: Chief Financial Officer | Restricted Stock Units | 1,954 | N/A | N/A | ||
Option | SHEOREY NEAL RAVI officer: Chief Financial Officer | Common Stock | 1,954 | N/A | N/A | ||
Sale | MUMMERT MARK RICHARD officer: SVP, Capital Projects | Common Stock | 843 | $135.53 | $114,250 | ||
Sale | BARICHIVICH JOHN CLARENCE III officer: VP, Cont.. | Common Stock | 1,475 | $132.17 | $194,951 | ||
Option | BARICHIVICH JOHN CLARENCE III officer: VP, Cont.. | Common Stock | 535 | N/A | N/A | ||
Option | BARICHIVICH JOHN CLARENCE III officer: VP, Cont.. | Restricted Stock Units | 535 | N/A | N/A | ||
Option | NORRIS ERIC officer: Presiden.. | Common Stock | 1,680 | N/A | N/A |
Patent |
---|
Application Filling date: 16 Sep 2020 Issue date: 1 Sep 2022 |
Grant Filling date: 4 Aug 2017 Issue date: 30 Aug 2022 |
Application Filling date: 10 Nov 2021 Issue date: 14 Apr 2022 |
Application Filling date: 31 Jan 2020 Issue date: 17 Mar 2022 |
Grant Utility: High density aqueous well fluids Filling date: 13 Feb 2020 Issue date: 8 Mar 2022 |
Application PROCESS AND HYDROCARBON SOLUBLE SALINE HYDRIDE CATALYST FOR HYDROGEN MEDIATED SALINE HYDRIDE INITIATED ANIONIC CHAIN TRANSFER POLYMERIZATION AND POLYMER DISTRIBUTION COMPOSITIONS PRODUCED THEREFROM Filling date: 25 Feb 2021 Issue date: 13 Jan 2022 |
Application PROCESS AND HYDROCARBON SOLUBLE SALINE HYDRIDE CATALYST FOR HYDROGEN MEDIATED SALINE HYDRIDE INITIATED ANIONIC CHAIN TRANSFER POLYMERIZATION AND POLYMER DISTRIBUTION COMPOSITIONS PRODUCED THEREFROM Filling date: 25 Feb 2021 Issue date: 6 Jan 2022 |
Application Filling date: 25 Oct 2019 Issue date: 23 Dec 2021 |
Application Filling date: 11 Oct 2019 Issue date: 23 Dec 2021 |
Application Filling date: 20 Dec 2019 Issue date: 16 Dec 2021 |
Quarter | Transcript |
---|---|
Q1 2024 2 May 2024 | Q1 2024 Earnings Call Transcript |
Q4 2023 15 Feb 2024 | Q4 2023 Earnings Call Transcript |
Q3 2023 2 Nov 2023 | Q3 2023 Earnings Call Transcript |
Q2 2023 3 Aug 2023 | Q2 2023 Earnings Call Transcript |
Insider | Compensation |
---|---|
Mr. Jerry Kent Masters Jr. (1961) Chairman, Pres & Chief Executive Officer | $1,980,000 |
Mr. Scott A. Tozier (1966) Executive Vice President & Chief Financial Officer | $1,170,000 |
Mr. Eric W. Norris (1967) Pres of Lithium Global Bus. Unit | $1,060,000 |
Mr. Netha N. Johnson Jr. (1971) Pres of Bromine Specialties Global Bus. Unit | $1,050,000 |
Mr. Raphael Goszcz Crawford (1976) Pres of Catalysts Global Bus. Unit | $893,350 |
Albemarle: Now It's Really Time To Look At Lithium (Rating Upgrade)
Albemarle: Was A Cyclical Lithium Bottom Reached In June?
Albemarle's Lithium Reset: Strong Buy Amid Cyclical Downturn And Structural Rebirth
Albemarle: This Minerals Stock Could Make A Good Portfolio Addition
Albemarle Stock: Lithium Glut Remains, But A Turn May Be Near (Rating Upgrade)
Standard Lithium Wins A Critical Victory
Albemarle: Finally Poised For Growth Again
Albemarle's Lithium Nightmare Might Become An Investor's Dream
An Opportunity To Buy Albemarle At Pre-EV Boom Price Levels
-
What's the price of Albemarle stock today?
One share of Albemarle stock can currently be purchased for approximately $80.5.
-
When is Albemarle's next earnings date?
Unfortunately, Albemarle's (ALB) next earnings date is currently unknown.
-
Does Albemarle pay dividends?
Yes, Albemarle pays dividends and its trailing 12-month yield is 1.82% with -14% payout ratio.It means that the company is paying a dividend while loss making. The last Albemarle stock dividend of $0.39 was paid on 3 Jan 2022.
-
How much money does Albemarle make?
Albemarle has a market capitalization of 10.48B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 31.38% to 9.62B US dollars.
-
What is Albemarle's stock symbol?
Albemarle Corporation is traded on the NYSE under the ticker symbol "ALB".
-
What is Albemarle's primary industry?
Company operates in the Basic Materials sector and Chemicals - Specialty industry.
-
How do i buy shares of Albemarle?
Shares of Albemarle can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Albemarle's key executives?
Albemarle's management team includes the following people:
- Mr. Jerry Kent Masters Jr. Chairman, Pres & Chief Executive Officer(age: 64, pay: $1,980,000)
- Mr. Scott A. Tozier Executive Vice President & Chief Financial Officer(age: 59, pay: $1,170,000)
- Mr. Eric W. Norris Pres of Lithium Global Bus. Unit(age: 58, pay: $1,060,000)
- Mr. Netha N. Johnson Jr. Pres of Bromine Specialties Global Bus. Unit(age: 54, pay: $1,050,000)
- Mr. Raphael Goszcz Crawford Pres of Catalysts Global Bus. Unit(age: 49, pay: $893,350)
-
How many employees does Albemarle have?
As Jul 2024, Albemarle employs 9,000 workers.
-
When Albemarle went public?
Albemarle Corporation is publicly traded company for more then 31 years since IPO on 22 Feb 1994.
-
What is Albemarle's official website?
The official website for Albemarle is albemarle.com.
-
Where are Albemarle's headquarters?
Albemarle is headquartered at 4250 Congress Street, Charlotte, NC.
-
How can i contact Albemarle?
Albemarle's mailing address is 4250 Congress Street, Charlotte, NC and company can be reached via phone at +98 2995700.
-
What is Albemarle stock forecast & price target?
Based on 6 Wall Street analysts` predicted price targets for Albemarle in the last 12 months, the avarage price target is $118.86. The average price target represents a 47.64% change from the last price of $80.5.
Albemarle company profile:

Albemarle Corporation
albemarle.comNYSE
9,000
Chemicals - Specialty
Basic Materials
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes in the areas of steroid chemistry and vitamins, life sciences, pharmaceutical industry, and other markets. It also provides cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Bromine segment offers bromine and bromine-based fire safety solutions; specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals for use in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, water purification, beef and poultry processing, and other industrial applications; and other specialty chemicals, such as tertiary amines for surfactants, biocides, and disinfectants and sanitizers. The Catalysts segment provides hydroprocessing, isomerization, and akylation catalysts; fluidized catalytic cracking catalysts and additives; and organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection markets. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.
Charlotte, NC 28209
CIK: 0000915913
ISIN: US0126531013
CUSIP: 012653101